# FDA Inspection 927861 - Seattle Reproductive Medicine, Inc., P.S. - May 27, 2015

Source: https://www.keypedia.com/records/fda_inspections/seattle-reproductive-medicine-inc-ps/ba6333ff-07d8-4de9-9cb0-7288782b7084
Source feed: FDA_Inspections

> FDA Inspection 927861 for Seattle Reproductive Medicine, Inc., P.S. on May 27, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 927861
- Company Name: Seattle Reproductive Medicine, Inc., P.S.
- Inspection Date: 2015-05-27
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1273730 - 2025-06-11](https://www.keypedia.com/records/fda_inspections/seattle-reproductive-medicine-inc-ps/489d06f2-ca7d-4c03-a098-2d52b0d18747)
- [FDA Inspection 1273730 - 2025-06-11](https://www.keypedia.com/records/fda_inspections/seattle-reproductive-medicine-inc-ps/2462c808-7f95-4464-aa32-1ffdb6ac1c94)
- [FDA Inspection 1144555 - 2021-06-16](https://www.keypedia.com/records/fda_inspections/seattle-reproductive-medicine-inc-ps/4b6d79b2-d805-4d7c-973b-4da73eab4095)
- [FDA Inspection 1144555 - 2021-06-16](https://www.keypedia.com/records/fda_inspections/seattle-reproductive-medicine-inc-ps/30085bc3-fef3-4b3a-bf40-f40ff303848c)
- [FDA Inspection 1144555 - 2021-06-16](https://www.keypedia.com/records/fda_inspections/seattle-reproductive-medicine-inc-ps/0850ca7e-cf14-449d-ba59-f4218d60f9b4)

Company: https://www.keypedia.com/companies/seattle-reproductive-medicine-inc-ps/13e322de-ec7b-4885-92bf-a81890751b66

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d